Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting of postneoadjuvant systemic therapy breast cancer specimens |
| Full bibliographic reference | Provenzano E, Bossuyt V, Viale G, Cameron D, Badve S, Denkert C, MacGrogan G, Penault-Llorca F, Boughey J, Curigliano G, Dixon JM, Esserman L, Fastner G, Kuehn T, Peintinger F, von Minckwitz G, White J, Yang W, Symmans WF; Residual Disease Characterization Working Group of the Breast International Group-North American Breast Cancer Group Collaboration. Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group. Mod Pathol. 2015;28(9):1185-1201. |
| Language | English |
| PubMed ID | 26205180 |
| Study design | Clinical trials, Experimental studies |
| Clinical area | Oncology, Pathology |
| Applies to the whole report or to individual sections of the report? | Intervention (exposure), Procedure/Method, Study characteristics (participants etc.), Terminology/definitions |
| Record last updated on | October 21, 2016 |